The collaboration aims to develop decision support tools — powered by data collection and machine learning — to assist surgeons planning and predicting outcomes for robotic-assisted joint replacements.
“Together we hope to create clinically validated decision support tools that rely on real-world patient and procedural data to inform actionable recommendations that help surgeons achieve predictable and reproducible clinical outcomes,” Nitin Goyal, MD, chief science, technology and innovation officer at Zimmer Biomet, said in a July 28 news release.
The decision support tools, which will be integrated into the Rosa Knee and Rosa Hip systems, will bolster Zimmer Biomet’s ZBEdge suite of smart, digital and robotic technologies, according to the company.
A team of HSS surgeons and Zimmer Biomet data scientists will work to develop and test hypotheses that use data-driven insights to address common clinical challenges associated with joint replacement. The goal is to use the validated hypotheses to inform the development of algorithms for the decision support tools.
“This agreement, which is our second collaboration with HSS in two years, advances our vision to accelerate impactful innovation through strategic third-party relationships,” said Ivan Tornos, COO at Zimmer Biomet.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.